Log In
Print
BCIQ
Print
Print this Print this
 

ASC-09, TMC310911

  Manage Alerts
Collapse Summary General Information
Company Johnson & Johnson
DescriptionHIV protease inhibitor
Molecular Target HIV protease
Mechanism of ActionHIV protease inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV in treatment-naïve patients
Regulatory Designation

Partner

Ascletis Pharmaceuticals Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today